Avanos Medical, Inc.
AVNS
$11.29
-$0.29-2.50%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 70.50M | 90.30M | 97.00M | 107.70M | 89.00M |
| Total Receivables | 111.50M | 110.20M | 104.80M | 132.80M | 131.90M |
| Inventory | 150.60M | 142.70M | 138.10M | 138.80M | 161.90M |
| Prepaid Expenses | 17.60M | 11.40M | 12.50M | 14.10M | 15.90M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.20M | 1.40M | -- | -- | 73.90M |
| Total Current Assets | 351.40M | 356.00M | 352.40M | 393.40M | 472.60M |
|
|
|||||
| Total Current Assets | 351.40M | 356.00M | 352.40M | 393.40M | 472.60M |
| Net Property, Plant & Equipment | 145.30M | 145.40M | 141.90M | 144.80M | 136.00M |
| Long-term Investments | 394.40M | 381.20M | 455.90M | 455.60M | 795.10M |
| Goodwill | 394.40M | 381.20M | 455.90M | 455.60M | 795.10M |
| Total Other Intangibles | 122.00M | 105.40M | 107.20M | 112.30M | 220.10M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 54.60M | 51.00M | 50.40M | 48.10M | 32.40M |
| Total Assets | 1.07B | 1.04B | 1.11B | 1.15B | 1.66B |
|
|
|||||
| Total Accounts Payable | 54.20M | 48.80M | 46.00M | 54.30M | 54.20M |
| Total Accrued Expenses | 70.00M | 60.50M | 54.90M | 73.30M | 76.50M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 18.90M | 19.80M | 19.80M | 20.30M | 23.10M |
| Total Finance Division Other Current Liabilities | 4.80M | 5.50M | 16.50M | 18.00M | 59.10M |
| Total Other Current Liabilities | 4.80M | 5.50M | 16.50M | 18.00M | 59.10M |
| Total Current Liabilities | 147.90M | 134.60M | 137.20M | 165.90M | 212.90M |
|
|
|||||
| Total Current Liabilities | 147.90M | 134.60M | 137.20M | 165.90M | 212.90M |
| Long-Term Debt | 93.40M | 95.70M | 98.00M | 125.30M | 152.60M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 21.40M | 21.80M | 23.10M | 24.60M | 26.50M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 27.00M | 10.60M | 10.10M | 9.90M | 34.50M |
| Total Liabilities | 289.70M | 262.70M | 268.40M | 325.70M | 426.50M |
|
|
|||||
| Common Stock & APIC | 1.69B | 1.69B | 1.68B | 1.68B | 1.68B |
| Retained Earnings | -778.60M | -777.20M | -700.40M | -707.00M | -309.70M |
| Treasury Stock & Other | -134.60M | -133.90M | -143.50M | -143.60M | -135.80M |
| Total Common Equity | 778.00M | 776.30M | 839.40M | 828.50M | 1.23B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 778.00M | 776.30M | 839.40M | 828.50M | 1.23B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 778.00M | 776.30M | 839.40M | 828.50M | 1.23B |
|
|
|||||